UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation

Liver transplantation, 2013-07, Vol.19 (7), p.690-700

2013

Volltextzugriff (PDF)

Long-term outcomes of donation after cardiac death liver allografts from a single center

Clinical transplantation, 2009-03, Vol.23 (2), p.168-173

2009

Volltextzugriff (PDF)

Successful Preoperative Transjugular Intrahepatic Portosystemic Shunt for Portal Decompression in Patients With Inflammatory Bowel Disease and Cirrhosis Requiring Surgical Intervention

Crohn's & colitis 360, 2024-07, Vol.6 (3), p.otae037

2024

Volltextzugriff (PDF)

Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation

Journal of clinical gastroenterology, 2004-11, Vol.38 (10), p.898-900

2004

Volltextzugriff (PDF)

Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single‐center experience

Liver transplantation, 2009-09, Vol.15 (9), p.1028-1035

2009

Volltextzugriff (PDF)

Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts

Annals of hepatology, 2012-09, Vol.11 (5), p.679-685

2012

Volltextzugriff (PDF)

Outcomes following liver transplantation in intensive care unit patients

World journal of hepatology, 2013-01, Vol.5 (1), p.26-32

2013

Volltextzugriff (PDF)

Inferior long‐term outcomes of liver‐kidney transplantation using donation after cardiac death donors: Single‐center and organ procurement and transplantation network analyses

Liver transplantation, 2014-06, Vol.20 (6), p.728-735

2014

Volltextzugriff (PDF)

Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy

Transplantation, 2014-12, Vol.98 (12), p.1323-1330

2014

Volltextzugriff (PDF)

Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome

Liver transplantation, 2006-08, Vol.12 (8), p.1244-1252

2006

Volltextzugriff (PDF)

Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus

Liver transplantation, 2011-06, Vol.17 (6), p.641-649

2011

Volltextzugriff (PDF)

Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience

Liver international, 2014-07, Vol.34 (6), p.e105-e110

2014

Volltextzugriff (PDF)

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C

Transplantation, 2004-01, Vol.77 (1), p.84

2004

Volltextzugriff (PDF)

Age is not a contraindication for orthotopic liver transplantation: a single institution experience with recipients older than 75 years

Hepatology international, 2012, Vol.6 (1), p.403-407

2012

Volltextzugriff (PDF)

Presentation of an acquired urea cycle disorder post liver transplantation

Liver transplantation, 2007-12, Vol.13 (12), p.1714-1716

2007

Volltextzugriff (PDF)

Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation

Liver transplantation, 2004-05, Vol.10 (5), p.599-606

2004

Volltextzugriff (PDF)

Sa1574 – Outcomes in Patients Receiving Plasmapheresis for Presumed Antibody-Mediated Liver Rejection: A Single Center Experience

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1239-S-1239

2019

Volltextzugriff (PDF)

Long-term outcomes after third liver transplant

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011-04, Vol.9 (2), p.98

2011

Volltextzugriff (PDF)

Liver cell necrosis: Cellular mechanisms and clinical implications

Gastroenterology, 1995, Vol.108 (1), p.252-275

1995

Volltextzugriff (PDF)

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C1

Transplantation, 2004-01, Vol.77 (1), p.84-92

2004

Volltextzugriff (PDF)

Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: Single-center and organ procurement and transplantation network analyses: Liver-Kidney Transplantation Using DCD Donors

Liver transplantation, 2014-06, Vol.20 (6), p.728-735

2014

Volltextzugriff (PDF)

The effects of various organ preservation solutions on hepatocyte membrane potentials, intracellular calcium concentrations, and outcome following liver transplantation

The American journal of surgery, 2000-02, Vol.179 (2), p.154-160

2000

Volltextzugriff (PDF)

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation: Protease Inhibitors after Liver Transplantation

Liver transplantation, 2013-07, Vol.19 (7), p.690-700

2013

Volltextzugriff (PDF)

Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis

Gastrointestinal endoscopy, 1999-06, Vol.49 (6), p.690-694

1999

Volltextzugriff (PDF)

Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus: DCD Liver Grafts for HCV Patients

Liver transplantation, 2011-06, Vol.17 (6), p.641-649

2011

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation

Long-term outcomes of donation after cardiac death liver allografts from a single center

Successful Preoperative Transjugular Intrahepatic Portosystemic Shunt for Portal Decompression in Patients With Inflammatory Bowel Disease and Cirrhosis Requiring Surgical Intervention

Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation

Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single‐center experience

Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts

Outcomes following liver transplantation in intensive care unit patients

Inferior long‐term outcomes of liver‐kidney transplantation using donation after cardiac death donors: Single‐center and organ procurement and transplantation network analyses

Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy

Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome

Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus

Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C

Age is not a contraindication for orthotopic liver transplantation: a single institution experience with recipients older than 75 years

Presentation of an acquired urea cycle disorder post liver transplantation

Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation

Sa1574 – Outcomes in Patients Receiving Plasmapheresis for Presumed Antibody-Mediated Liver Rejection: A Single Center Experience

Long-term outcomes after third liver transplant

Liver cell necrosis: Cellular mechanisms and clinical implications

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C1

Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: Single-center and organ procurement and transplantation network analyses: Liver-Kidney Transplantation Using DCD Donors

The effects of various organ preservation solutions on hepatocyte membrane potentials, intracellular calcium concentrations, and outcome following liver transplantation

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation: Protease Inhibitors after Liver Transplantation

Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis

Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus: DCD Liver Grafts for HCV Patients

Suchergebnisse filtern